Symbol Therapeutics is developing a modified therapeutic protein to enhance immune regulation in autoimmune diseases

Scientific approach

Semaphorin3A is a protein involved in immune regulation, in addition to other functions. The modified Sema3A, T-Sema3A, is expected to restore immune homeostasis and increase immune regulation through specific binding to a novel immune receptor.

link to Symbol Therapeutics page




Prof. Elias Toubi, MD – Co-Inventor

Prof. Zahava Vadasz, MD, PhD – Co-Inventor

Prof. (Emeritus) Gera Neufeld – Co-Inventor

Adi Sagiv, PhD – CSO

Scroll to top